20413

    524164

    IOLCP

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    IOL CHEM AND PHARMA LTD Share Price Today

    IOL CHEM AND PHARMA LTD is currently trading at ₹142.96, down by ₹7.34 from the previous close. The stock touched an intraday high of ₹150.89 and a low of ₹140.27 during the latest trading session. Over the past one year, IOL CHEM AND PHARMA LTD has delivered a return of 52.13%, while the stock has gained 16.95% in the last one month.

    IOL CHEM AND PHARMA LTD performance

    Today’s low Today’s high
    ₹ 140.27 ₹ 150.89
    ₹ 142.70
    52 week low 52 week high
    ₹ 67.19 ₹ 151.20
    ₹ 142.70
    Open Price ₹ 150.70
    Prev. Close ₹ 150.31
    Volume (Shares) 3796371.00
    Total traded value ₹ 5417.42
    Upper Circuit ₹ 180.37
    Lower Circuit ₹ 120.25
    info

    Investment Returns

    Over 1 Month 16.95% Over 3 Months 90.12% Over 6 Months 79.13% Over 1 Year 52.13%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    IOL CHEM AND PHARMA LTD fundamentals


    • Market cap (Cr) 4,179.20
    • P/E Ratio (TTM) 32.03
    • Beta 1.37
    • Book Value / share 61.26
    • Return on equity 6.12%
    • EPS (TTM) 4.98
    • Dividend yield 0.67%
    • Net profit/quarter (Cr) 53.18
    info icon alternate text
    • Market cap (Cr) 4,187.20
    • P/E Ratio (TTM) 32.03
    • Beta 1.22
    • Book Value / share 61.26
    • Return on equity 6.12%
    • EPS (TTM) 4.98
    • Dividend yield 0.67%
    • Net profit/quarter (Cr) 53.18
    info icon alternate text

    IOL CHEM AND PHARMA LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 619.45
    Operating Expense 550.36
    Net Profit 53.18
    Net Profit Margin (%) 8.58
    Earnings Per Share (EPS) 1.81
    EBITDA 94.30
    Effective Tax Rate (%) 24.91
    Particulars DEC 2025 (Values in Cr)
    Revenue 580.39
    Operating Expense 546.92
    Net Profit 20.58
    Net Profit Margin (%) 3.54
    Earnings Per Share (EPS) 0.70
    EBITDA 51.35
    Effective Tax Rate (%) 25.29
    Particulars SEP 2025 (Values in Cr)
    Revenue 567.53
    Operating Expense 533.89
    Net Profit 30.00
    Net Profit Margin (%) 5.28
    Earnings Per Share (EPS) 1.02
    EBITDA 63.98
    Effective Tax Rate (%) 25.96
    Particulars JUN 2025 (Values in Cr)
    Revenue 551.69
    Operating Expense 513.52
    Net Profit 33.96
    Net Profit Margin (%) 6.15
    Earnings Per Share (EPS) 1.16
    EBITDA 69.52
    Effective Tax Rate (%) 25.42
    Particulars MAR 2025 (Values in Cr)
    Revenue 527.78
    Operating Expense 487.40
    Net Profit 31.62
    Net Profit Margin (%) 5.99
    Earnings Per Share (EPS) 5.38
    EBITDA 67.46
    Effective Tax Rate (%) 29.57
    Particulars MAR 2026 (Values in Cr)
    Revenue 2319.06
    Operating Expense 2144.69
    Net Profit 137.72
    Net Profit Margin (%) 5.93
    Earnings Per Share (EPS) 4.69
    EBITDA 279.16
    Effective Tax Rate (%) 25.33
    Particulars MAR 2025 (Values in Cr)
    Revenue 2079.21
    Operating Expense 1963.72
    Net Profit 101.00
    Net Profit Margin (%) 4.85
    Earnings Per Share (EPS) 17.20
    EBITDA 224.57
    Effective Tax Rate (%) 26.75
    Particulars MAR 2024 (Values in Cr)
    Revenue 2132.79
    Operating Expense 1980.21
    Net Profit 135.42
    Net Profit Margin (%) 6.34
    Earnings Per Share (EPS) 23.07
    EBITDA 261.59
    Effective Tax Rate (%) 25.85
    Particulars MAR 2023 (Values in Cr)
    Revenue 2217.11
    Operating Expense 2053.19
    Net Profit 139.98
    Net Profit Margin (%) 6.31
    Earnings Per Share (EPS) 23.84
    EBITDA 252.09
    Effective Tax Rate (%) 26.12
    Particulars MAR 2022 (Values in Cr)
    Revenue 2184.02
    Operating Expense 1979.29
    Net Profit 165.66
    Net Profit Margin (%) 7.58
    Earnings Per Share (EPS) 28.22
    EBITDA 274.39
    Effective Tax Rate (%) 25.65
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 57.49
    ROE % 6.13
    ROCE % 8.82
    Total Debt to Total Equity 0.05
    EBITDA Margin 10.81
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 274.49
    ROE % 8.62
    ROCE % 12.21
    Total Debt to Total Equity 0.04
    EBITDA Margin 12.22
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 256.81
    ROE % 9.60
    ROCE % 13.54
    Total Debt to Total Equity 0.04
    EBITDA Margin 11.33
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 237.15
    ROE % 12.04
    ROCE % 16.20
    Total Debt to Total Equity 0.03
    EBITDA Margin 12.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 57.48
    ROE % 6.12
    ROCE % 8.82
    Total Debt to Total Equity 0.05
    EBITDA Margin 10.80
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 274.46
    ROE % 8.69
    ROCE % 12.27
    Total Debt to Total Equity 0.04
    EBITDA Margin 12.27
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 256.61
    ROE % 9.66
    ROCE % 13.61
    Total Debt to Total Equity 0.04
    EBITDA Margin 11.37
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 236.80
    ROE % 12.50
    ROCE % 17.09
    Total Debt to Total Equity 0.02
    EBITDA Margin 12.56
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 214.69
    ROE % 42.87
    ROCE % 53.83
    Total Debt to Total Equity 0.03
    EBITDA Margin 31.32
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 208.15
    Total Assets 2382.07
    Total Liabilities 2382.07
    Total Equity 1687.66
    Share Outstanding 29
    Price to Book Ratio 1.06
    Return on Assets (%) 4.24
    Return on Capital (%) 5.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 142.89
    Total Assets 2244.40
    Total Liabilities 2244.40
    Total Equity 1611.51
    Share Outstanding 5
    Price to Book Ratio 1.32
    Return on Assets (%) 5.98
    Return on Capital (%) 8.18
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 21.83
    Total Assets 2022.13
    Total Liabilities 2022.13
    Total Equity 1507.72
    Share Outstanding 5
    Price to Book Ratio 1.10
    Return on Assets (%) 6.88
    Return on Capital (%) 8.77
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 139.99
    Total Assets 1962.30
    Total Liabilities 1962.30
    Total Equity 1392.28
    Share Outstanding 5
    Price to Book Ratio 1.49
    Return on Assets (%) 8.54
    Return on Capital (%) 11.68
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 207.94
    Total Assets 2381.78
    Total Liabilities 2381.78
    Total Equity 1687.41
    Share Outstanding 29
    Price to Book Ratio 1.06
    Return on Assets (%) 4.24
    Return on Capital (%) 5.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 142.62
    Total Assets 2243.97
    Total Liabilities 2243.97
    Total Equity 1611.33
    Share Outstanding 5
    Price to Book Ratio 1.32
    Return on Assets (%) 6.03
    Return on Capital (%) 8.24
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 20.90
    Total Assets 2020.61
    Total Liabilities 2020.61
    Total Equity 1506.55
    Share Outstanding 5
    Price to Book Ratio 1.10
    Return on Assets (%) 6.92
    Return on Capital (%) 8.82
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 137.88
    Total Assets 1960.29
    Total Liabilities 1960.29
    Total Equity 1390.27
    Share Outstanding 5
    Price to Book Ratio 1.49
    Return on Assets (%) 8.45
    Return on Capital (%) 11.56
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 364.74
    Total Assets 1610.09
    Total Liabilities 1610.09
    Total Equity 1260.43
    Share Outstanding 5
    Price to Book Ratio 2.56
    Return on Assets (%) 27.61
    Return on Capital (%) 35.27
    Particulars MAR 2025 (Values in Cr)
    Net Income 137.96
    Cash from Operations 196.94
    Cash from Investing -154.18
    Cash from Financing 46.04
    Net change in Cash 70.48
    Free Cash Flow 410.49
    Particulars MAR 2024 (Values in Cr)
    Net Income 181.65
    Cash from Operations 331.80
    Cash from Investing -190.98
    Cash from Financing -92.50
    Net change in Cash 6.30
    Free Cash Flow 605.97
    Particulars MAR 2023 (Values in Cr)
    Net Income 188.65
    Cash from Operations 169.37
    Cash from Investing -120.00
    Cash from Financing -4.11
    Net change in Cash -1.84
    Free Cash Flow 381.19
    Particulars MAR 2022 (Values in Cr)
    Net Income 224.85
    Cash from Operations 155.63
    Cash from Investing -120.52
    Cash from Financing -1.64
    Net change in Cash -29.11
    Free Cash Flow 308.91
    Particulars MAR 2025 (Values in Cr)
    Net Income 137.89
    Cash from Operations 197.00
    Cash from Investing -154.23
    Cash from Financing 46.04
    Net change in Cash 70.49
    Free Cash Flow 410.55
    Particulars MAR 2024 (Values in Cr)
    Net Income 182.64
    Cash from Operations 332.48
    Cash from Investing -191.39
    Cash from Financing -92.50
    Net change in Cash 6.57
    Free Cash Flow 606.65
    Particulars MAR 2023 (Values in Cr)
    Net Income 189.49
    Cash from Operations 170.24
    Cash from Investing -119.19
    Cash from Financing -4.11
    Net change in Cash -0.16
    Free Cash Flow 381.53
    Particulars MAR 2022 (Values in Cr)
    Net Income 222.84
    Cash from Operations 153.62
    Cash from Investing -120.62
    Cash from Financing -1.64
    Net change in Cash -31.22
    Free Cash Flow 306.90
    Particulars MAR 2021 (Values in Cr)
    Net Income 571.39
    Cash from Operations 522.03
    Cash from Investing -317.25
    Cash from Financing -58.28
    Net change in Cash 4.25
    Free Cash Flow 630.24
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 13.14 1.53 243.77 23.12 38.85
    BLISS GVS PHARMA LTD. 524.85 42.60 4.66 5566.36 118.35 552.90
    CIPLA LTD 1456.95 30.92 3.41 117699.02 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 354.50 15.64 2.56 1043.33 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 22.24 4.09 243.77 23.12 38.85
    AMRUTAJAN HEALTH LTD 549.45 24.63 4.29 1588.49 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8216.55 107.31 23.53 20541.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 524.85 56.62 4.81 5566.36 118.35 552.90

    IOL CHEM AND PHARMA LTD shareholding pattern

    Holding
    40.77%
    57.47%
    1.71%
    0.02%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    IOL CHEM AND PHARMA LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    142.38 -5.27 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 144.30
    • 26 Days 131.20
    • 10 Days 139.70
    • 50 Days 120.30
    • 12 Days 138.40
    • 100 Days 107.00
    • 20 Days 134.10
    • 200 Days 97.70
    146.77 PIVOT
    First Support 145.04 First Resistance 148.94 Second Support 142.87 Second Resistance 150.67 Third Support 141.14 Third Resistance 152.84
    RSI 70.34 ADX 23.33 MACD 6.60 Williams % R -5.10 Commodity Channel Index (CCI) 243.81
    Date 2026-07-01 Week 2096280.00 Same Day 1603432.00 Month 1249698.00
    1 Year 1.38 3 Year 1.25
    Over 1 Month
    16.95% down
    Over 1 Year
    52.13% down
    Over 3 Months
    90.12% down
    Over 3 Years
    21.95% down
    Over 6 Months
    79.13% down
    Over 5 Years
    3.94% down

    IOL CHEM AND PHARMA LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Feb 2026 1.0 Interim 17 Feb 2026 Equity shares
    18 Feb 2025 4.0 Interim 18 Feb 2025 Equity shares
    16 Feb 2024 5.0 Interim 16 Feb 2024 Equity shares
    17 Feb 2023 4.0 Interim 17 Feb 2023 Equity shares
    15 Feb 2022 4.0 Interim 16 Feb 2022 Equity shares
    08 Sep 2021 2.0 Final 12 Sep 2021 Equity shares
    17 Nov 2020 4.0 Interim 18 Nov 2020 Equity shares
    18 Mar 2020 3.0 Interim 1 19 Mar 2020 Equity shares
    Ex-Date Old FV NEW FV Record Date
    11 Mar 2025 10.0 2.0 11 Mar 2025
    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Feb 2026 1.0 Interim 17 Feb 2026 Equity shares
    18 Feb 2025 4.0 Interim 18 Feb 2025 Equity shares
    16 Feb 2024 5.0 Interim 16 Feb 2024 Equity shares
    17 Feb 2023 4.0 Interim 17 Feb 2023 Equity shares
    15 Feb 2022 4.0 Interim 16 Feb 2022 Equity shares
    08 Sep 2021 2.0 Final 12 Sep 2021 Equity shares
    17 Nov 2020 4.0 Interim 18 Nov 2020 Equity shares
    18 Mar 2020 3.0 Interim 1 19 Mar 2020 Equity shares
    Ex-Date Old FV NEW FV Record Date
    11 Mar 2025 10.0 2.0 11 Mar 2025

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of IOL Chemicals & Pharmaceuticals Ltd?

    Answer Field

    IOL Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 142.96 & for BSE ₹ 143.05 as on Jul 03 2026 03:30 PM.

    What is the Market Cap of IOL Chemicals & Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of IOL Chemicals & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 03 2026 03:30 PM.

    What is the 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 151.20 and ₹ 67.19 and for BSE is ₹ 151.05 and ₹ 67.14.

    What is 1 year return for IOL Chemicals & Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 56.85%.

    What is the P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM the price-to-earnings (PE) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 32.03.

    What is the PB ratio of IOL Chemicals & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM, the price-to-book (PB) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 61.26.

    How to Buy IOL Chemicals & Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in IOL Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy IOL Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy IOL Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “IOL Chemicals & Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |